Nations must start testing and regulating chemicals and chemical products as closely as the current systems that safeguard prescription drugs or risk ...
Emergent BioSolutions Inc. (NYSE: EBS) today announced the exercise of contract option and modification valued at approximately $20 million to supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S.